F.M. Nunes et al. / Applied Catalysis A: General 468 (2013) 88–94
91
Acetone/Hexane. Twenty-three fractions were collected, and frac-
tion 9 contained (1R,2S,4R,8R)-p-menthane-2,8,9-triol (1b).
(1R,2S,4R,8R)-p-menthane-2,8,9-triol (1b): Yellow amorphous
solid. IR
(cm−1): 754; 840; 954; 994; 1037; 1108; 1143;
max
1299; 1376; 1453; 1663; 2868; 2928; 3392. ESI–MS: m/z 211
([M+Na]+, C10H20O3). 13C NMR (CD3OD, 100 MHz) ı: 19.0(C-7),
21.1(C-10), 28.3(C-5), 29.5(C-6), 34.9(C-3), 37.9(C-1), 38.0(C-4),
69.1(C-9), 71.9(C-2), 75.3(C-8).
2.7.2. Kinetic monitoring of the biotransformation of (4R)- and
(4S)-carvone
M. circinelloides was cultivated in 250 mL Erlenmeyer flasks con-
taining 50 mL of Czapeck medium for 18 h at 28 ◦C under stirring
(125 rpm). Next, 20 L of the substrate ((4R)- or (4S)-carvone) was
added to each Erlenmeyer flask (48 flasks for each carvone). At 4 h
intervals, three flasks were removed, and the mycelium was sep-
arated from the liquid medium. Then, the aqueous portion was
extracted with 20 mL of dichloromethane and 20 mL of n-butyl
alcohol. In the end, 192 samples were obtained (i.e., triplicates of
sixteen samples for each carvone extracted with dichloromethane
and n-butyl alcohol).
3. Results and discussion
3.1. Biotransformation of (R)-carvone by L. theobromae
The study on the biotransformation of carvone was initiated
using whole-cells of the phytopathogen fungus L. theobromae.
The minimum inhibitory concentration (MIC) of (R)-carvone (2)
on the fungal growth was evaluated, and concentrations of 0.2
and 0.5 L/mL of this monoterpene exhibited no inhibition of the
microorganism’s growth. At higher concentrations, (R)-carvone
(2) exhibited either fungistatic (1.0 or 1.5 L/mL) or fungicide
(2.5 L/mL) effects.
The biotransformation products from the culture broth of
the MIC experiments were analyzed by GC–MS. In the experi-
ments performed with monoterpene concentrations of 0.2, 0.5 and
1.0 L/mL, three products, BP-1 (10.6 min), BP-2 (14.4 min) and
BP-3 (15.8 min), were observed besides the substrate 2 (11.3 min).
Their ratio varied in each experiment, and the highest substrate
bioconversion was achieved in the experiments performed with 0.2
and 0.5 L/mL of 2. In the experiments with higher monoterpene
concentrations (1.5 and 2.5 L/mL), only 2 (major compound) and
the product with a retention time of 10.6 min (BP-1) were observed.
Thus, concentrations between 0.2 and 0.5 L/mL of 2 were consid-
ered optimal for the biotransformation of this monoterpene by L.
theobromae.
The
biotransformation
products
extracted
with
dichloromethane were analyzed by GC–MS [Shimadzu CG–MS
2010 plus series equipped with a Restek Rtx® – 5MS capillary
column (30 m × 0.25 mm × 0.25 m)] using helium as the carrier
gas. The oven temperature was programmed at 60 ◦C for 5 min
followed by 60–240 ◦C at 6 ◦C/min and subsequently isothermal
maintained for 5 min. Injector port: 220 ◦C, interface: 240 ◦C, split
ratio: 1:30. The data were acquired using an ionization voltage
of 70 eV. The identification of the compounds was based on mass
spectra by comparison with the NIST Library.n-Butyl alcohol
extracts were analyzed by HPLC–MS/MS. The equipment was
composed of an Alliance 2695 HPLC (Waters, Manchester, UK)
coupled to a Quattro-LC ESI triple-quadrupole mass spectrometer
(Waters, Manchester, UK). The chromatographic separation was
performed on a 4.6 mm × 250 mm Phenomenex Synergy C-18
column (Phenomenex®) with a flow rate of 1 mL min−1. The
chromatographic method employed an isocratic condition with
a mobile phase composed of acetonitrile:water (70:30, v/v) with
0.1% of trifluoroacetic acid (JT Baker). The mass spectrometer
was operated in the ESI positive mode. During these analyses, a
selected ion monitoring experiment (SIM), scanning [M+Na]+ in
both quadrupoles (m/z 211 → m/z 211), was used to monitor the
accumulation of the biotransformation products.
Column chromatography of the crude products from the exper-
to its high volatility.
The main products from the bioreduction of (R)-carvone (2)
are reported in the literature as dihydrocarvone (3) [6,13], carveol
(4) [9] and dihydrocarveol/neodihydrocarveol (5) [6,13]. Therefore,
we decided to chemically reduce (R)-carvone (2) and compare the
products with those obtained from the biotransformation exper-
iment. Analysis of the reaction products by GC–MS allowed the
identification of a mixture of carveol (4) and neodihydrocarveol
(5) with respective retention times of 11.1 and 10.6 min.
A comparison of both the retention time and mass spectra
of neodihydrocarveol (5) with those from the biotransformation
products allowed the identification of BP-1 as 5.
Dihydrocarveol (5): Colorless oil. MS (EI, 70 eV) m/z (%): 154 (3);
136 (72); 121 (84); 107 (97); 93 (100); 79 (84); 67 (63); 55 (59); 41
(75).
8(9)-p-menthen-2,10-diol (6): colorless oil. IR ꢀmax (cm−1): 477;
1034; 1240; 1372; 1451; 1553; 1653; 1723; 2844; 2923; 3399. MS
(EI, 70 eV) m/z (%): 152 (6), 134 (34), 119 (38), 105 (29), 95 (100), 81
(59), 67 (68), 55 (79), 41 (82). 1H NMR (500 MHz, CDCl3) ı: 0.98 (d,
J = 6.7 Hz, H-7); 1.25 (s, H-5ꢀ); 1.47 (m, H-6); 1.47 (ddl, H-3ꢀ); 1.56
(m, H-1); 1.82 (ddd, J = 12.3; 5.7; 3.7 Hz, H-5ꢀꢀ); 1.98 (ddd, J = 13.7;
5.7; 3.2 Hz, H-3ꢀꢀ); 2.38 (ddd, J = 12.4; 5.3; 2.7 Hz, H-4); 3.91 (dl,
J = 2.5 Hz, H-2); 4.15 (s, H-10); 4.90 (s, H-9ꢀ); 5.05 (s, H-9ꢀꢀ). 13C NMR
(125 MHz, CDCl3) ı: 18.5 (C-7); 28.4 (C-6); 32.1 (C-5); 33.9 (C-4);
36.2 (C-1); 39.2 (C-3); 65.4 (C-10); 71.1 (C-2); 108.2 (C-9); 153.7
(C-8).
The biotransformation product BP-2 was identified as
a
diastereoisomeric mixture (de 39.6%) of 8(9)-p-menthen-2,10-diol
(6) using one- and two-dimensional NMR spectra as well as com-
parison with the literature data reported for this monoterpene [19].
The 1H–13C heteronuclear multiple bond correlation (HMBC) spec-
trum of 6 allowed the unambiguous assignment of C-5 (ı 32.1) and
C-6 (ı 28.4), which were reversely assigned in a previous study [19].
Compound BP-3 was identified as (1R,2S,4R,8S)-p-menthane-
2,8,9-triol (1a) by comparison of its NMR data with those reported
in the literature [2].
The hypothesis of (1R,2S,4R,8S)-p-menthane-2,8,9-triol (1a)
being an artifact product formed by the addition of water to the
exocyclic C C bond in 10-hydroxyneodihydrocarveol (6) was con-
sidered. Therefore, biotransformation product 6 was submitted to
the same conditions (culture broth, pH, temperature and time) used
in the biotransformation experiments in the absence of microor-
ganisms. In this case, compound 6 was completely recovered from
the medium confirming 1a as a biotransformation product.
(1R,2S,4R,8S)-p-menthane-2,8,9-triol (1a): Yellow amorphous
solid. IR ꢀmax (cm−1): 754; 840; 954; 994; 1037; 1108; 1143; 1299;
1376; 1453; 1663; 2868; 2928; 3392. ESI–MS: m/z 211 ([M+Na]+,
C10H20O3). MS (EI, 70 eV) m/z (%): 173 (1); 157 (28); 139 (78); 121
(41); 109 (3); 95 (21); 81(51); 43 (100). 1H NMR (500 MHz, CDCl3)
ı: 0.95 (d, J = 6.4 Hz, H-7); 0.99 (d, J = 12.3 Hz, H-5ꢀ); 1.01 (s, H-10);
1.32 (ddd, J = 13.5; 13.4; 2.0 Hz, H-3ꢀ); 1.39 (dd, J = 12.5; 3.2 Hz, H-
6ꢀ); 1.44 (m, H-4); 1.64 (dl, J = 12.3 Hz, H-5ꢀꢀ); 1.99 (brq, J = 12,1 Hz,
H-1); 2.07 (dd, J = 13.4; 2.0 Hz, H-3ꢀꢀ); 3.43 (d, J = 11.3 Hz, H-9ꢀ); 3.55
(d, J = 11.3; H-9ꢀꢀ). 13C NMR (125 MHz, CDCl3) ı: 18.6 (C-7); 19.2 (C-
10); 27.8 (C-5); 28.4 (C-6); 33.5 (C-3); 36.3 (C-1); 36.5 (C-4); 68.8
(C-9); 71.2 (C-2); 75.0 (C-8). 13C NMR (CD3OD, 100 MHz) ı: 19.0(C-
7), 20.7(C-10), 27.3(C-5), 29.5(C-6), 35.9(C-3), 37.9(C-1), 38.0(C-4),
69.2(C-9), 71.8(C-2), 75.4(C-8).